블로그
- HK inno. N’s Decision on K-CAB’s Co-Promotion Partner 2023.10.05 PHARMABIO HIT-DIGEST HK inno.N, a leading South Korean pharmaceutical company that specializes in developing and manufacturing pharmaceutical products, is currently grappling with a crucial decision
- CTD Module The Common Technical Document is divided into five modules: Module 1 ) Administrative and prescribing Module 2 )Overview and summary of modules 3 to 5 / 모듈 3~5의 자료개요 및 요약 Module 3 ) Quality (pharmaceutical
- 제넥신, 코로나19 DNA백신 인도네시아 특허관련 collaboration with Genexine, a pharmaceutical company from South Korea. "Although there is n.......
- 제넥신, Kalbe Farma Set to Test Covid-19 Vaccine - 제넥신, 칼베 코로나19 백신 협력에 대한 기사 The PT Kalbe Farma Tbk (KLBF) pharmaceutical company is set to tackle the
- 중국 시노팜 본사 출장 방문 I visited to China National Accord Medicines Corporation which is the largest pharmaceutical group in
- Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19 catalysed the development of novel coronavirus vaccines across the biotech industry, both by pharmaceutical The first COVID-19 vaccine in China is expected to be ready for clinical trials by the end of April,
- AMC Advance market commitments From Wikipedia, the free encyclopedia An advance market commitment is a binding government or other financial entity, used to guarantee a viable market if a vaccine or other medicine is
- FKI head Kang to serve third term Kang Shin-ho, chairman of Korea's top pharmaceutical company Dong-A, said yesterday that if asked, he "As chairman Lee Kun-hee (of Samsung Group) said, Korea's economy is at a critical phase, sandwiched
← 이전
2 페이지